United States Animal Parasite Prevention and Control Drugs Market was valued at USD 1.5 Billion in 2022 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 7.6% from 2024 to 2030.
Start
The U.S. Animal Parasite Prevention And Control Drugs Market Is Experiencing Significant Growth, Driven By The Increasing Need To Protect Both Companion Animals And Livestock From Various Parasitic Threats. In 2022, The Market Was Valued At Approximately $4.5 Billion And Is Projected To Reach $7.2 Billion By 2030, Reflecting A Compound Annual Growth Rate (Cagr) Of 7.5% From 2024 To 2030. This Surge Is Propelled By Heightened Awareness Of Animal Health, Rising Pet Ownership, And The Economic Impact Of Parasitic Infections On Livestock Productivity.
Key Market Players Include Zoetis, Merck Animal Health, Bayer Animal Health, Boehringer Ingelheim, Elanco Animal Health, And Ceva Animal Health. These Companies Offer A Range Of Products, Such As Oral Medications, Topical Treatments, And Injectables, Targeting Parasites Like Fleas, Ticks, Mites, And Worms. The Market Is Segmented By Animal Type, Product Type, Drug Class, Administration Route, And Application. Notably, Ectoparasiticides Are Expected To Dominate, Accounting For Over Half Of The Market Share, Due To The Prevalence Of External Parasites And Their Impact On Animal Health.
Recent Developments Underscore The Market'S Dynamism. In October 2024, The U.S. Food And Drug Administration Approved Elanco Animal Health'S Oral Drug, Credelio Quattro, Designed To Protect Dogs Against Six Parasitic Infections. This Monthly Chewable Tablet Addresses Flea And Tick Infestations, As Well As Infections From Roundworms, Hookworms, And Tapeworms, While Also Preventing Heartworm Disease. Elanco Plans To Launch Credelio Quattro In The First Quarter Of 2025, Anticipating Its Success Alongside Other Products Like Zenrelia, Aimed At Treating Skin Diseases In Dogs.
Similarly, Zoetis Has Raised Its 2024 Profit And Revenue Forecasts, Citing Strong Demand For Its Pet Medicines And Vaccines. The Company'S Second-Quarter Revenue Reached $2.36 Billion, With A 10.7% Increase In Companion Animal Segment Sales. Key Drivers Include Medications Like Librela, Solensia, Simparica, Simparica Trio, Apoquel, And Cytopoint, Highlighting The Market'S Focus On Comprehensive Parasite Control Solutions For Pets.
The Market'S Growth Is Also Influenced By The Rising Incidence Of Parasitic Infections, Which Pose Risks To Animal Health And Public Safety. The Reemergence Of Parasites Like The Cattle Screwworm, Detected In Southern Mexican Cattle In November 2024, Emphasizes The Need For Effective Prevention And Control Measures. This Parasite Feeds On The Living Flesh Of Mammals, Including Livestock And Pets, And Its Spread Could Have Severe Economic And Health Implications. The U.S. Department Of Agriculture'S Decision To Halt Cattle Imports From Mexico Following This Discovery Highlights The Importance Of Vigilance And Proactive Strategies In Managing Parasitic Threats.
In Summary, The U.S. Animal Parasite Prevention And Control Drugs Market Is Evolving Rapidly, With Significant Investments In Research And Development Leading To Innovative Products That Address The Complex Challenges Posed By Animal Parasites. As The Industry Continues To Grow, Stakeholders Must Remain Attentive To Emerging Threats And Adapt To The Changing Landscape Of Animal Health Needs.
Get an In-Depth Research Analysis of the US Animal Parasite Prevention and Control Drugs Market Size And Forecast [2025-2032]
Boehringer Ingelheim
Bayer
Zoetis
Dechra Pharmaceuticals
Chanelle Pharma
Merck Animal Health
Elanco
Virbac
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Animal Parasite Prevention and Control Drugs Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Animal Parasite Prevention and Control Drugs Market
Livestock
Companion Animals
Wild Animals
Endoparasiticides
Ectoparasiticides
Combination Drugs
Avermectins
Pyrethroids
Benzimidazoles
Macrocyclic Lactones
Oral
Topical
Injectable
Preventive Treatment
Curative Treatment
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Animal Parasite Prevention and Control Drugs Market Research Analysis
1. Introduction of the US Animal Parasite Prevention and Control Drugs Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Animal Parasite Prevention and Control Drugs Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Animal Parasite Prevention and Control Drugs Market, By Type
6. US Animal Parasite Prevention and Control Drugs Market, By Application
7. US Animal Parasite Prevention and Control Drugs Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Animal Parasite Prevention and Control Drugs Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/